The results of a randomized study on the use of long-acting octreotide in hepatocellular carcinoma.
Borbath
Ivan
I
Horsmans
Yves
Y
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003692:Delayed-Action Preparations; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D015282:Octreotide / Q000008:administration & dosage*; D016032:Randomized Controlled Trials as Topic
D018931:Antineoplastic Agents, Hormonal; D003692:Delayed-Action Preparations; D015282:Octreotide